Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | CXCR3 | P49682 | 14/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4620514 | 0.84 | TSHR (0.49) | TSHRKDM4EHTTTDP1MAPK1 | |
| SCHEMBL17204582 | 0.79 | TSHR (0.48) | TSHRKDM4EHTTTDP1MAPK1 | |
| SCHEMBL3505958 | 0.76 | MAPK1 (0.51) | TSHRKDM4EHTTTDP1MAPK1 | |
| SCHEMBL14484582 | 0.76 | MAPK1 (0.51) | TSHRKDM4EHTTTDP1MAPK1 | |
| SCHEMBL9000551 | 0.75 | TSHR (0.52) | TSHRKDM4EHTTTDP1MAPK1 | |
| Myrtenol SCHEMBL24281940 | 0.74 | TSHR (0.58) | TSHRKDM4EHTTTDP1MAPK1 | |
| Myrtenol SCHEMBL155709 | 0.74 | TSHR (0.58) | TSHRKDM4EHTTTDP1MAPK1 | |
| Myrtenol SCHEMBL4826734 | 0.74 | TSHR (0.58) | TSHRKDM4EHTTTDP1MAPK1 | |
| Myrtenol SCHEMBL3836506 | 0.74 | TSHR (0.58) | TSHRKDM4EHTTTDP1MAPK1 | |
| Myrtenol SCHEMBL15536292 | 0.74 | TSHR (0.58) | TSHRKDM4EHTTTDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001085663-A1 | BICYCLOHEPTENYL COMPOUNDS | COGNIS DEUTSCHLAND GMBH & CO. KG (DE) | 2001-11-15 | — | — | WO | disclosed |